We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Arjunolic acid: beneficial role in type 1 diabetes and its associated organ pathophysiology.
- Authors
Manna, Prasenjit; Sil, Parames C
- Abstract
In this review article, we describe the most recent development of the beneficial effect of arjunolic acid (AA) in reducing type 1 diabetic pathophysiology. Diabetic mellitus is a serious and growing health problem worldwide. Increasing evidence suggest that oxidative stress plays a pivotal role in the pathogenesis of diabetes and its associated complications. Use of antioxidant supplements as a complimentary therapeutic approach in diabetes has, therefore, been seriously considered worldwide. AA, a natural pentacyclic triterpenoid saponin, is well known for various biological functions including antioxidant activity. It could prevent the increased production of ROS, RNS, AGEs, and the 8OHdG/2dG ratio and increase the intracellular antioxidant defence system. Signal transduction studies showed that AA could prevent hyperglycaemia induced activation of MAPKs, PKC, NF-κB signalling cascades and apoptotic cell death. Combining, AA supplements could be regarded as beneficial therapeutics in the treatment of diabetes and its associated complications.
- Publication
Free radical research, 2012, Vol 46, Issue 7, p815
- ISSN
1029-2470
- Publication type
Journal Article
- DOI
10.3109/10715762.2012.683431